These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33556972)

  • 1. [Treatment of IBS with Lactobacillus plantarum 299v: Therapeutic success increases with length of treatment - real-life data of a non-interventional study in Germany].
    Krammer H; Storr M; Madisch A; Riffel J
    Z Gastroenterol; 2021 Feb; 59(2):125-134. PubMed ID: 33556972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 4 weeks of Lactobacillus plantarum 299v supplementation on nutritional status, enteral nutrition tolerance, and quality of life in cancer patients receiving home enteral nutrition - a double-blind, randomized, and placebo-controlled trial.
    Kaźmierczak-Siedlecka K; Folwarski M; Ruszkowski J; Skonieczna-Żydecka K; Szafrański W; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9684-9694. PubMed ID: 33015813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome.
    Ducrotté P; Sawant P; Jayanthi V
    World J Gastroenterol; 2012 Aug; 18(30):4012-8. PubMed ID: 22912552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome.
    Niedzielin K; Kordecki H; Birkenfeld B
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1143-7. PubMed ID: 11711768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study.
    Rudzki L; Ostrowska L; Pawlak D; Małus A; Pawlak K; Waszkiewicz N; Szulc A
    Psychoneuroendocrinology; 2019 Feb; 100():213-222. PubMed ID: 30388595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?
    Bixquert Jiménez M
    Rev Esp Enferm Dig; 2009 Aug; 101(8):553-64. PubMed ID: 19785495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Lactobacillus plantarum DSM 9843 (LP299V) in the Prevention of Antibiotic-Associated Gastrointestinal Symptoms in Children-Randomized, Double-Blind, Placebo-Controlled Study.
    Olek A; Woynarowski M; Ahrén IL; Kierkuś J; Socha P; Larsson N; Önning G
    J Pediatr; 2017 Jul; 186():82-86. PubMed ID: 28438377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Lactobacillus plantarum 299v versus Placebo in symptomatic improvement of irritable bowel syndrome patients.
    ; Babar AN; Hassan MK; Ullah F; Ullah A
    J Pak Med Assoc; 2022 Mar; 72(3):404-408. PubMed ID: 35320214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probiotic strain Lactobacillus plantarum 299v increases iron absorption from an iron-supplemented fruit drink: a double-isotope cross-over single-blind study in women of reproductive age.
    Hoppe M; Önning G; Berggren A; Hulthén L
    Br J Nutr; 2015 Oct; 114(8):1195-202. PubMed ID: 26428277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Lactobacillus plantarum 299v (DSM 9843) in cancer patients receiving home enteral nutrition - study protocol for a randomized, double-blind, and placebo-controlled trial.
    Kaźmierczak-Siedlecka K; Folwarski M; Skonieczna-Żydecka K; Ruszkowski J; Makarewicz W
    Nutr J; 2020 Sep; 19(1):98. PubMed ID: 32917221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Oral Intake of
    Jung K; Kim A; Lee JH; Cho D; Seo J; Jung ES; Kang HJ; Roh J; Kim W
    Nutrients; 2022 May; 14(10):. PubMed ID: 35631156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Nordström EA; Teixeira C; Montelius C; Jeppsson B; Larsson N
    Benef Microbes; 2021 Oct; 12(5):441-465. PubMed ID: 34365915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized clinical trial: effect of Lactobacillus plantarum 299 v on symptoms of irritable bowel syndrome.
    Stevenson C; Blaauw R; Fredericks E; Visser J; Roux S
    Nutrition; 2014 Oct; 30(10):1151-7. PubMed ID: 25194614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.
    Guglielmetti S; Mora D; Gschwender M; Popp K
    Aliment Pharmacol Ther; 2011 May; 33(10):1123-32. PubMed ID: 21418261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
    Andresen V; Gschossmann J; Layer P
    Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of New
    Oh JH; Jang YS; Kang D; Chang DK; Min YW
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.